381 related articles for article (PubMed ID: 27136631)
1. Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
Noguera-Morel L; Azorin D; Xirotagaros G
Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136631
[TBL] [Abstract][Full Text] [Related]
2. [Sporotrichoid cutaneous leishmaniasis].
López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
[No Abstract] [Full Text] [Related]
3. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
Solomon M; Ollech A; Pavlotsky F; Barzilai A; Schwartz E; Baum S; Astman N
Acta Derm Venereol; 2024 Apr; 104():adv35089. PubMed ID: 38682801
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
[TBL] [Abstract][Full Text] [Related]
6. Unusual form of cutaneous leishmaniasis: erysipeloid form.
Mnejja M; Hammami B; Chakroun A; Achour I; Charfeddine I; Chakroun A; Turki H; Ghorbel A
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Apr; 128(2):95-7. PubMed ID: 21251895
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
Munir A; Janjua SA; Hussain I
Acta Dermatovenerol Croat; 2008; 16(2):60-4. PubMed ID: 18541100
[TBL] [Abstract][Full Text] [Related]
8. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
[TBL] [Abstract][Full Text] [Related]
9. Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.
Masood S; Naveed S; Alvi RU
Trop Doct; 2012 Apr; 42(2):120-1. PubMed ID: 22337728
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A
Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
[TBL] [Abstract][Full Text] [Related]
11. Slow-growing scaly erythematous plaque on the face and scalp of an elderly woman.
Torres Garcia Y; Escutia Muñoz B; Botella Estrada R
Actas Dermosifiliogr; 2013 Oct; 104(8):715-6. PubMed ID: 24011741
[No Abstract] [Full Text] [Related]
12. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
Bogenrieder T; Lehn N; Landthaler M; Stolz W
Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupoid leishmaniasis: a case report.
Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
[TBL] [Abstract][Full Text] [Related]
15. Rhinophyma-like cutaneous leishmaniasis.
Youssef M; Soua Y; Belhadjali H
Indian J Dermatol Venereol Leprol; 2014; 80(6):537-8. PubMed ID: 25382513
[No Abstract] [Full Text] [Related]
16. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Brito NC; Rabello A; Cota GF
PLoS One; 2017; 12(9):e0184777. PubMed ID: 28926630
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
Salmanpour R; Handjani F; Nouhpisheh MK
J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
[TBL] [Abstract][Full Text] [Related]
19. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
20. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
Romero GA; Molinet FJ; Noronha EF
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
